August 18, 2017 9:21 PM ET


Company Overview of Juno Therapeutics, Inc.

Executive Profile

Richard D. Klausner M.D.

Co-Founder and Director, Juno Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 16 different industries.

See Board Relationships


Dr. Richard D. Klausner, also known as Rick, M.D., is a Co-Founder of Mindstrong, Inc. and serves as its Executive Chairman. Dr. Klausner serves as the Chief Strategy Advisor for USAID. Dr. Klausner serves as Scientific Advisor of Cyterix Pharmaceuticals Inc. He served as the Chief Medical Officer and Senior Vice President of Illumina Inc. from September 23, 2013 to March 31st 2016 and served as its Interim General Manager of Oncology since 2013. Dr. Klausner was responsible ...

Corporate Headquarters

307 Westlake Avenue North
Seattle, Washington 98109

United States

Phone: 206-582-1600
Fax: --

Board Members Memberships

Member of The Board of Directors and Member of Advisory Board
Director and Member of Scientific Advisory Board
Co-Founder and Executive Chairman
Co-Founder and Director


Yale University
Duke University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$12,000
Unexercisable Options$12,000
Total Number of Options$24,000

Total Compensation

Total Annual Cash Compensation$250,000
Total Calculated Compensation$598,890

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juno Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at